# Neurological Disorders and Treatments

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/neurological-disorders-and-treatments-2/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the investigation of neuroprotective agents such as Citicoline and Cerebrolysin in the context of oxidative stress, ischemic stroke, brain injury, glaucoma, and neurodegenerative diseases like Alzheimer's. The research explores their mechanisms of action, effects on mitochondrial dysfunction, neuroprotection, and potential for promoting neuroregeneration. |
| Domain | Life Sciences |
| Field | Neuroscience |
| OpenAlex ID | t13796 |
| Works | 131 |

## Topic papers all

Showing 15 of 131.

- [Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk](https://scholariq.org/papers/intestinal-microbial-metabolism-of-phosphatidylcholine-and-cardiovascular-risk/)
- [COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS](https://scholariq.org/papers/collaborative-overview-of-randomized-trials-of-antiplatelet-therapy-1-prevention/)
- [The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease](https://scholariq.org/papers/the-cholinergic-system-in-the-pathophysiology-and-treatment-of-alzheimer-s/)
- [Stroke in China: advances and challenges in epidemiology, prevention, and management](https://scholariq.org/papers/stroke-in-china-advances-and-challenges-in-epidemiology-prevention-and/)
- [Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders](https://scholariq.org/papers/discriminative-accuracy-of-plasma-phospho-tau217-for-alzheimer-disease-vs-other/)
- [The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease](https://scholariq.org/papers/the-topographical-and-neuroanatomical-distribution-of-neurofibrillary-tangles/)
- [Thrombolysis for acute ischaemic stroke](https://scholariq.org/papers/thrombolysis-for-acute-ischaemic-stroke/)
- [Protein kinase C activation and the development of diabetic complications.](https://scholariq.org/papers/protein-kinase-c-activation-and-the-development-of-diabetic-complications/)
- [Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease](https://scholariq.org/papers/trial-of-solanezumab-for-mild-dementia-due-to-alzheimer-s-disease/)
- [Reliability of the Fugl-Meyer Assessment of Sensorimotor Recovery Following Cerebrovascular Accident](https://scholariq.org/papers/reliability-of-the-fugl-meyer-assessment-of-sensorimotor-recovery-following/)
- [The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis](https://scholariq.org/papers/the-prevalence-of-neuropsychiatric-symptoms-in-alzheimer-s-disease-systematic/)
- [Global brain inflammation in stroke](https://scholariq.org/papers/global-brain-inflammation-in-stroke/)
- [Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline](https://scholariq.org/papers/effectiveness-of-cholinesterase-inhibitors-and-memantine-for-treating-dementia/)
- [Vascular Cognitive Impairment and Dementia](https://scholariq.org/papers/vascular-cognitive-impairment-and-dementia/)
- [Migraine](https://scholariq.org/papers/migraine/)

## Topic primary papers

Showing 15 of 23.

- [COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS](https://scholariq.org/papers/collaborative-overview-of-randomized-trials-of-antiplatelet-therapy-1-prevention/)
- [Post-stroke cognitive impairment: epidemiology, mechanisms and management.](https://scholariq.org/papers/post-stroke-cognitive-impairment-epidemiology-mechanisms-and-management/)
- [Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression](https://scholariq.org/papers/cerebral-microvascular-complications-of-type-2-diabetes-stroke-cognitive/)
- [Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic Strategy](https://scholariq.org/papers/diabetic-vascular-complications-pathophysiology-biochemical-basis-and-potential/)
- [Leitlinien für Diagnostik und Therapie in der Neurologie](https://scholariq.org/papers/leitlinien-fur-diagnostik-und-therapie-in-der-neurologie/)
- [Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications](https://scholariq.org/papers/brain-injury-with-diabetes-mellitus-evidence-mechanisms-and-treatment/)
- [Neuroprotective agents in the management of glaucoma](https://scholariq.org/papers/neuroprotective-agents-in-the-management-of-glaucoma/)
- [Antidiabetic Drugs in the Treatment of Alzheimer’s Disease](https://scholariq.org/papers/antidiabetic-drugs-in-the-treatment-of-alzheimer-s-disease/)
- [Hepatotoxicity and endothelial dysfunction induced by high choline diet and the protective effects of phloretin in mice](https://scholariq.org/papers/hepatotoxicity-and-endothelial-dysfunction-induced-by-high-choline-diet-and-the/)
- [Neurocognitive impairment in type 2 diabetes mellitus](https://scholariq.org/papers/neurocognitive-impairment-in-type-2-diabetes-mellitus/)
- [European Academy of Neurology and European Federation of Neurorehabilitation Societies guideline on pharmacological support in early motor rehabilitation after acute ischaemic stroke](https://scholariq.org/papers/european-academy-of-neurology-and-european-federation-of-neurorehabilitation/)
- [Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial](https://scholariq.org/papers/efficacy-and-safety-of-cerebrolysin-in-neurorecovery-after-moderate-severe/)
- [Neuroprotective agents in Acute Ischemic Stroke—A Reality Check](https://scholariq.org/papers/neuroprotective-agents-in-acute-ischemic-stroke-a-reality-check/)
- [Current Drug Treatment of Acute Ischemic Stroke: Challenges and Opportunities](https://scholariq.org/papers/current-drug-treatment-of-acute-ischemic-stroke-challenges-and-opportunities/)
- [Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I—a randomized, placebo-controlled, double-blind, Asian-Pacific trial](https://scholariq.org/papers/safety-and-efficacy-of-cerebrolysin-in-acute-brain-injury-and-neurorecovery/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.